Is the US prepared to deal with another pandemic or widespread health crisis?

Based on recent assessments, there are significant concerns among public health experts about current U.S. pandemic preparedness, even as some structural and scientific capabilities remain in place.

Signs of Weakened Preparedness

Funding and workforce cuts: Multiple reports from 2025–2026 point to substantial reductions in public health infrastructure. The President's proposed FY 2026 budget for the Centers for Disease Control and Prevention amounts to a 53 percent reduction in funding as compared to FY 2024, reflecting proposed cuts to CDC and its sister agency, ATSDR. Within that, CDC's Public Health Emergency Preparedness program – the primary source of federal funding for state and local emergency preparedness – faces a 52 percent funding reduction.

This isn't just proposed — it's already having effects. CDC lost approximately one quarter of its civilian workforce between fiscal years 2024 and 2026, with reductions spanning global health, health promotion, scientific research, and communications. Lab capacity has also been hit: concurrent demands on public health laboratories in 2025 — including confirmatory testing across 48 separate measles outbreaks, a tuberculosis outbreak in Kansas City, sustained H5N1 surveillance, and a severe influenza season — occurred simultaneously with federal funding terminations affecting more than $8.9 billion in Epidemiology and Laboratory Capacity program support.

These cuts are already causing real-world detection delays. Public health cuts inhibited responses to the summer 2026 outbreak of the food-borne parasite cyclospora, as cuts to lab equipment and CDC staff with parasitic-infection expertise contributed to the largest reporting delay in outbreak cases at the CDC in 15 years.

Leadership gaps: The White House office created specifically for pandemic coordination has been hollowed out. In 2025, Gerald Parker resigned as head of the office, leaving the office with no employees.

Coordination problems: A February 2026 GAO report found structural issues in how HHS tracks readiness. HHS does not collect or analyze information on jurisdictions' ability to meet the 15 public health and four health care preparedness capabilities and any related gaps, despite having identified these capabilities as national guidance describing skills jurisdictions need to respond to and recover from public health threats.

Uneven state-level readiness: The 2026 "Ready or Not" report found wide variation across the country, placing 20 states in the high-performance tier, 17 states and the District of Columbia in the middle-performance tier, and 13 states in the low-performance tier. The same report notes this comes against a backdrop of real strain: in 2025, the country faced the most severe flu season in nearly a decade, rising measles outbreaks, continued H5N1 avian influenza activity, and a growing number of extreme weather events—all while the federal systems built over decades to help states prepare for and respond to emergencies came under significant strain.

Budget shortfalls acknowledged even in government planning documents: HHS's own medical countermeasure strategy flags a major gap: if funding continues at the proposed FY 2026 levels over the projected five-year period, an estimated $33.5 billion funding gap from the total projected need is expected.

Areas of Continued Investment

Not everything points downward. Scientific R&D on next-generation countermeasures continues: work is underway to develop vaccine and antiviral countermeasures for H5N1, including pursuing advanced testing of a whole-virus universal influenza vaccine candidate, BPL-1357, that provided near-universal protection against a wide range of influenza viruses in non-clinical models.

There's also a federal strategic emphasis on supply chains: the Administration for Strategic Preparedness and Response's 2026-2029 Strategic Plan makes securing America's medical supply chain a major objective, including efforts to strengthen domestic manufacturing capacity and reduce dependency on foreign sourcing.

Bottom Line

The weight of expert and government-watchdog assessments in 2025–2026 suggests the U.S. is less prepared than it was a few years ago, not more. The combination of steep proposed/enacted CDC budget cuts, a quarter of the CDC workforce lost, an empty White House pandemic-policy office, and GAO-identified coordination gaps paints a picture of eroding — rather than strengthening — capacity, even as targeted investments in vaccine science and domestic manufacturing continue. Readiness also varies significantly by state, meaning the honest answer is "it depends where you live" as much as it depends on the type of crisis.